Making a follow-up plan – ICST

Making a follow-up plan

Tutorial presented by Dr Andrew Yeoman, National Liver Clinical Lead and Consultant Hepatologist, Aneurin Bevan University Health Board

Step 3 of the All-Wales Abnormal Liver Blood tests pathway is to make a follow-up plan for patients. Patients who have ongoing findings of abnormality on the further investigations and are at high risk of fibrosis, will require referral to Hepatology for further investigations and more intense management. Patients who have no abnormalities on further investigations are at low risk of fibrosis, can be managed in primary care.

Management in primary care addresses the patient’s risk factors, including alcohol cessation and weight management.

Making a follow-up plan

Tutorial presented by Dr Andrew Yeoman, National Liver Clinical Lead and Consultant Hepatologist, Aneurin Bevan University Health Board

Step 3 of the All-Wales Abnormal Liver Blood tests pathway is to make a follow-up plan for patients. Patients who have ongoing findings of abnormality on the further investigations and are at high risk of fibrosis, will require referral to Hepatology for further investigations and more intense management. Patients who have no abnormalities on further investigations are at low risk of fibrosis, can be managed in primary care.

Management in primary care addresses the patient’s risk factors, including alcohol cessation and weight management.

Further Investigations

Mark as Understood

Resources

All-Wales Abnormal Liver Blood Test Pathway

A standardised, efficient approach to the management of abnormal liver blood tests.

More like this

Weight loss management in primary care

Management of alcohol misuse

Managing patients in primary care who have a low risk of fibrosis

© Institute of Clinical Science and Technology (ICST) 2020 Support: support@icst.org.uk